ArticleFrontiers in immunology2021
Deep Phenotyping of CD11c
Open access · goldAbstract readComparative Study
In one paragraph
Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.
0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
6.3field-weighted citation impact, top 2% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
47 citing papers in PubMed, 91 citations in OpenAlex.
- Immune profiling of patients with extranodal natural killer/T cell lymphoma treated with daratumumab.Annals of hematology · 2024Trial
- Multiomic Immune Profiling of Pediatric Transplant Recipients Identifies Cell States Associated with Vaccine Response.Clinical journal of the American Society of Nephrology : CJASN · 2026Article
- CD21Frontiers in aging · 2026Article
- Astrocyte-derived extracellular vesicles as antigen-specific therapy for neuromyelitis optica spectrum disorder in the mouse model.bioRxiv : the preprint server for biology · 2025Article
- Immune-cell profiling to guide stratification and treatment of patients with rheumatic diseases.Nature reviews. Rheumatology · 2025Review
- Spectral Flow Cytometry: The Current State and Future of the Technology.International journal of molecular sciences · 2025Review
- Aberrant B cell receptor signaling responses in circulating double-negative 2 B cells from radiographic axial spondyloarthritis patients.Journal of translational autoimmunity · 2025Article
- Age-Associated B Cells in Autoimmune Diseases: Pathogenesis and Clinical Implications.Clinical reviews in allergy & immunology · 2025Review
- Multi-dimensional analysis of B cells reveals the expansion of memory and regulatory B-cell clusters in humans living in rural tropical areas.Clinical and experimental immunology · 2025Article
- Phosphatidylcholine-specific B cells are enriched among atypical CD11cFrontiers in immunology · 2025Article
- Immune-derived cardiac autonomic signatures: predicting autonomic responses to exercise from B-cell phenotypes.Frontiers in neuroscience · 2025Article
- CD226Frontiers in immunology · 2025Article
- Leveraging immune checkpoint inhibitors in lung cancer patients with pre-existing autoimmune disease: clinical insights, optimal timing, and predictive biomarkers for optimal treatment outcomes.Frontiers in immunology · 2025Review
- CD21Frontiers in immunology · 2025Article
- Rise of a CD27European journal of immunology · 2024Article
- Extrafollicular CD19Journal of translational autoimmunity · 2024Article
- CD9 and Aryl Hydrocarbon Receptor Are Markers of Human CD19+CD14+ Atypical B Cells and Are Dysregulated in Systemic Lupus Erythematous Disease.Journal of immunology (Baltimore, Md. : 1950) · 2024Article
- CD27 is not an ideal marker for human memory B cells and can be modulated by IL-21 upon stimulated by Anti-CD40.Scientific reports · 2024Article
- Mitochondria Activity and CXCR4 Collaboratively Promote the Differentiation of CD11cImmune network · 2024Article
- Exploring the Role of PD-1 in the Autoimmune Response: Insights into Its Implication in Systemic Lupus Erythematosus.International journal of molecular sciences · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors at 4 institutions in 3 countries.
Hector Rincon-ArevaloDepartment of Nephrology and Intensive Medical Care, Charité- Universitätsmedizin Berlin, Berlin, Germany.
Annika WiedemannDepartment of Rheumatology and Clinical Immunology, Charité- Universitätsmedizin Berlin, Berlin, Germany.
Ana-Luisa StefanskiDepartment of Rheumatology and Clinical Immunology, Charité- Universitätsmedizin Berlin, Berlin, Germany.
Marie LettauDepartment of Rheumatology and Clinical Immunology, Charité- Universitätsmedizin Berlin, Berlin, Germany.
Franziska SzelinskiDepartment of Rheumatology and Clinical Immunology, Charité- Universitätsmedizin Berlin, Berlin, Germany.
Sebastian FuchsRoche Pharma Research and Early Development, Immunology, Infectious Diseases and Ophthalmology (I2O) Discovery and Translational Area, Roche Innovation Center Basel, Basel, Switzerland.
Andreas Philipp FreiRoche Pharma Research and Early Development, Immunology, Infectious Diseases and Ophthalmology (I2O) Discovery and Translational Area, Roche Innovation Center Basel, Basel, Switzerland.
Malte SteinbergRoche Pharma Research and Early Development, Immunology, Infectious Diseases and Ophthalmology (I2O) Discovery and Translational Area, Roche Innovation Center Basel, Basel, Switzerland.
Tony Kam-ThongRoche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Klas HatjeRoche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Baerbel KellerDepartment of Rheumatology and Clinical Immunology, Faculty of Medicine, Medical Center-University of Freiburg, Freiburg im Breisgau, Germany.
Klaus WarnatzDepartment of Rheumatology and Clinical Immunology, Faculty of Medicine, Medical Center-University of Freiburg, Freiburg im Breisgau, Germany.
Andreas RadbruchDeutsches Rheumaforschungszentrum, Berlin, Germany.
Andreia C LinoDeutsches Rheumaforschungszentrum, Berlin, Germany.
Eva SchrezenmeierDepartment of Nephrology and Intensive Medical Care, Charité- Universitätsmedizin Berlin, Berlin, Germany.
Thomas DörnerDepartment of Rheumatology and Clinical Immunology, Charité- Universitätsmedizin Berlin, Berlin, Germany.
Charité - Universitätsmedizin Berlin · DERoche (Switzerland) · CHGerman Rheumatism Research Centre · DEUniversity of Freiburg · DE
Funding
No grant is acknowledged in the PubMed record.
Abstract
Circulating CD11c
Indexed as
AutoimmunityFlow CytometryImmunophenotypingLymphocyte ActivationADP-ribosyl Cyclase 1B7-H1 AntigenBiomarkersB-LymphocytesCase-Control StudiesCD11c AntigenHumansLupus Erythematosus, SystemicMembrane GlycoproteinsPhenotypeProgrammed Cell Death 1 ReceptorReceptors, Complement 3dADP-ribosyl Cyclase 1B7-H1 AntigenBiomarkersCD11c AntigenCD274 protein, humanCD38 protein, humanMembrane GlycoproteinsPDCD1 protein, humanProgrammed Cell Death 1 ReceptorReceptors, Complement 3dTumor Necrosis Factor Receptor Superfamily, Member 7atypical B cellsB cellCD11cCD21lupuspSSSLE
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.